Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

NCT00105235 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

NIH

Sponsor class

Conditions

Liver Disease
Liver Transplantation

Interventions

DRUG: Alemtuzumab
DRUG: Cyclosporine
DRUG: Mycophenolate mofetil
DRUG: Tacrolimus
PROCEDURE: Liver transplant
PROCEDURE: Immunosuppression withdrawal

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]